
Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea
Strategic Partnership to Accelerate Korean Market Entry, Business Development, and Long-Term Value Creation Across Vivasor’s $100 Billion Pipeline of Clinical-Stage Biopharmaceutical Assets PR Audio SAN






